PATHOLOGIC STAGE IV ESOPHAGEAL ADENOCARCINOMA AJCC V8
Clinical trials for PATHOLOGIC STAGE IV ESOPHAGEAL ADENOCARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new PATHOLOGIC STAGE IV ESOPHAGEAL ADENOCARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for PATHOLOGIC STAGE IV ESOPHAGEAL ADENOCARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental combo targets incurable esophageal cancer
Disease control OngoingThis early-phase study tested a drug called adavosertib combined with radiation therapy for people with advanced esophageal or stomach cancer that cannot be surgically removed. The goal was to find the safest dose and see how well the combination works. Only 4 people took part, s…
Matched conditions: PATHOLOGIC STAGE IV ESOPHAGEAL ADENOCARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:58 UTC
-
Radiation boosts chemo for stomach and esophageal cancer?
Disease control OngoingThis study tests whether adding radiation therapy to standard chemotherapy helps people with HER2-negative esophageal or stomach cancer that has spread to a few other spots in the body (oligometastatic). About 314 participants will receive either chemotherapy alone or chemotherap…
Matched conditions: PATHOLOGIC STAGE IV ESOPHAGEAL ADENOCARCINOMA AJCC V8
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 26, 2026 07:26 UTC